Professor of Research in Pharmacology, University of Virginia; Chief Executive Officer and Co-Founder, KeViRx
Beth Sharlow has more than 25 years of drug discovery experience obtained in academia and industry with a focus on assay development, high-throughput screening, lead discovery and preclinical development. Her research has focused on the identification and validation of molecular targets as a means to discover signaling mechanisms between cells and, ultimately, form the foundation for drug development.
“Be creative, flexible and opportunistic. Stay positive and keep a good sense of humor. And network, network, network.”